Acute Myeloid Leukemia, Version 3.2017

被引：325

作者：

O'Donnell, Margaret R. ^{[1
]}

Tallman, Martin S. ^{[2
]}

Abboud, Camille N. ^{[3
,4
]}

Altman, Jessica K. ^{[5
]}

Appelbaum, Frederick R. ^{[6
]}

Arber, Daniel A. ^{[7
]}

Bhatt, Vijaya ^{[8
]}

Bixby, Dale ^{[9
]}

Blum, William ^{[10
,11
]}

Coutre, Steven E. ^{[7
]}

De Lima, Marcos ^{[12
,13
]}

Fathi, Amir T. ^{[14
]}

Fiorella, Melanie ^{[15
]}

Foran, James M. ^{[16
]}

Gore, Steven D. ^{[17
]}

Hall, Aric C. ^{[18
]}

Kropf, Patricia ^{[19
]}

Lancet, Jeffrey ^{[20
]}

Maness, Lori J. ^{[8
]}

Marcucci, Guido ^{[1
]}

Martin, Michael G. ^{[21
]}

Moore, Joseph O. ^{[22
]}

Olin, Rebecca ^{[23
]}

Peker, Deniz ^{[24
]}

Pollyea, Daniel A. ^{[25
]}

Pratz, Keith ^{[26
]}

Ravandi, Farhad ^{[27
]}

Shami, Paul J. ^{[28
]}

Stone, Richard M. ^{[29
]}

Strickland, Stephen A. ^{[30
]}

Wang, Eunice S. ^{[31
]}

Wieduwilt, Matthew ^{[32
]}

Gregory, Kristina

Ogba, Ndiya

机构：

[1] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[4] Washington Univ, Sch Med, St Louis, MO 63130 USA

[5] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[6] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[7] Stanford Canc Inst, Stanford, CA USA

[8] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[9] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[10] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[11] Solove Res Inst, Columbus, OH USA

[12] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[13] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[14] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[15] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA

[16] Mayo Clin, Ctr Canc, Rochester, MN USA

[17] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[18] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[19] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[20] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[21] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[22] Duke Canc Inst, Raleigh, NC USA

[23] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[24] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA

[25] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[26] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[27] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[28] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[29] Dana Farber Brigham & Womens Canc Ctr, Milford, MA USA

[30] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[31] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[32] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2017年 / 15卷 / 07期

关键词：

STEM-CELL TRANSPLANTATION; RISK MYELODYSPLASTIC SYNDROME; ACUTE MYELOGENOUS LEUKEMIA; HIGH-DOSE CYTARABINE; 1ST COMPLETE REMISSION; AGED; 60; YEARS; HEALTH-ORGANIZATION CLASSIFICATION; CONVENTIONAL CARE REGIMENS; PHASE-III TRIAL; C-KIT MUTATIONS;

D O I：

10.6004/jnccn.2017.0116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age < 60 years) and older (age >= 60 years) adult patients.

引用

页码：926 / +

页数：24

共 108 条

[1] A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [J].

Al-Ali, H. K. ;

Brand, R. ;

van Biezen, A. ;

Finke, J. ;

Boogaerts, M. ;

Fauser, A. A. ;

Egeler, M. ;

Cahn, J-Y ;

Arnold, R. ;

Biersack, H. ;

Niederwieser, D. ;

de Witte, T. .

LEUKEMIA, 2007, 21 (09) :1945-1951

[2] Therapy-related acute myeloid leukemia with favorable cytogenetics: Still favorable? [J].

Aldoss, Ibrahim ;

Pullarkat, Vinod .

LEUKEMIA RESEARCH, 2012, 36 (12) :1547-1551

[3]

Altman JK, 2015, BLOOD, V126, P321, DOI DOI 10.1182/blood.V126.23.321.321

[4] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17) [J].

Amadori, Sergio ;

Suciu, Stefan ;

Stasi, Roberto ;

Salih, Helmut R. ;

Selleslag, Dominik ;

Muus, Petra ;

De Fabritiis, Paolo ;

Venditti, Adriano ;

Ho, Anthony D. ;

Luebbert, Michael ;

Thomas, Xavier ;

Latagliata, Roberto ;

Halkes, Constantijn J. M. ;

Falzetti, Franca ;

Magro, Domenico ;

Guimaraes, Jose E. ;

Berneman, Zwi ;

Specchia, Giorgina ;

Karrasch, Matthias ;

Fazi, Paola ;

Vignetti, Marco ;

Willemze, Roel ;

de Witte, Theo ;

Marie, Jean-Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) :4424-+

[5] Age and acute myeloid leukemia [J].

Appelbaum, FR ;

Gundacker, H ;

Head, DR ;

Slovak, ML ;

Willman, CL ;

Godwin, JE ;

Anderson, JE ;

Petersdorf, SH .

BLOOD, 2006, 107 (09) :3481-3485

[6] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert ;

Thiele, Jurgen ;

Borowitz, Michael J. ;

Le Beau, Michelle M. ;

Bloomfield, Clara D. ;

Cazzola, Mario ;

Vardiman, James W. .

BLOOD, 2016, 127 (20) :2391-2405

[7] Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: A review and updated results of the Australian Leukemia Study Group [J].

Bishop, JF ;

Matthews, JP ;

Young, GAR ;

Bradstock, K ;

Lowenthal, RM .

LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) :315-327

[8] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [J].

Bishop, JF ;

Matthews, JP ;

Young, GA ;

Szer, J ;

Gillett, A ;

Joshua, D ;

Bradstock, K ;

Enno, A ;

Wolf, MM ;

Fox, R ;

Cobcroft, R ;

Herrmann, R ;

VanDerWeyden, M ;

Lowenthal, RM ;

Page, F ;

Garson, OM ;

Juneja, S .

BLOOD, 1996, 87 (05) :1710-1717

[9]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[10] Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine [J].

Blum, William ;

Garzon, Ramiro ;

Klisovic, Rebecca B. ;

Schwind, Sebastian ;

Walker, Alison ;

Geyer, Susan ;

Liu, Shujun ;

Havelange, Violaine ;

Becker, Heiko ;

Schaaf, Larry ;

Mickle, Jon ;

Devine, Hollie ;

Kefauver, Cheryl ;

Devine, Steven M. ;

Chan, Kenneth K. ;

Heerema, Nyla A. ;

Bloomfield, Clara D. ;

Grever, Michael R. ;

Byrd, John C. ;

Villalona-Calero, Miguel ;

Croce, Carlo M. ;

Marcucci, Guido .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (16) :7473-7478

← 1 2 3 4 5 6 7 8 9 10 →